Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Pyridine derivatives >  Isoxazolo[5,4-c]pyridin-3-amine (9CI)

Isoxazolo[5,4-c]pyridin-3-amine (9CI)

Basic information Safety Supplier Related

Isoxazolo[5,4-c]pyridin-3-amine (9CI) Basic information

Product Name:
Isoxazolo[5,4-c]pyridin-3-amine (9CI)
Synonyms:
  • Isoxazolo[5,4-c]pyridin-3-amine
  • Isoxazolo[5,4-c]pyridin-3-amine (9CI)
  • Isoxazolo[5,4-c]pyridin-3-ylamine
  • 1,2]oxazolo[5,4-c]pyridin-3-amine
CAS:
114080-94-3
MF:
C6H5N3O
MW:
135.12
Product Categories:
  • organic building block
  • PYRIDINE
Mol File:
114080-94-3.mol
More
Less

Isoxazolo[5,4-c]pyridin-3-amine (9CI) Chemical Properties

storage temp. 
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
Appearance
Light yellow to yellow Solid
More
Less

Safety Information

HS Code 
2934999090
More
Less

Isoxazolo[5,4-c]pyridin-3-amine (9CI) Usage And Synthesis

Synthesis

546-88-3

68325-15-5

114080-94-3

General procedure for the synthesis of isoxazolo[5,4-c]pyridin-3-amines from acetohydroxamic acid and 3-chloro-4-cyanopyridine: Intermediate 1: Synthesis of isoxazolo[5,4-c]pyridin-3-amines. To a solution of N,N-dimethylformamide (DMF, 6.0 mL) of 3-chloro-4-cyanopyridine (1.13 g, 8.36 mmol) was sequentially added potassium carbonate (1.69 g, 12.2 mmol) and acetohydroxamic acid (0.91 g, 12.2 mmol). The reaction mixture was stirred at room temperature overnight, and when the reaction was complete, it was diluted with ethyl acetate (EtOAc, 200 mL) and washed sequentially with saturated aqueous sodium bicarbonate (200 mL) and saturated aqueous sodium chloride (100 mL). The aqueous layer was back-extracted with ethyl acetate (200 mL), and the organic layers were combined, dried with anhydrous magnesium sulfate (MgSO?), and concentrated under reduced pressure. The crude product was purified by fast column chromatography (FCC, eluent: methanol/dichloromethane solution containing 2N ammonia) to give isoxazolo[5,4-c]pyridin-3-amine (0.447 g, 41% yield). Mass spectrum (ESI+): m/z of C?H?N?O was calculated as 135.04 and measured as 136.2 ([M+H]+). 1H NMR (d6-DMSO): δ 8.93 (d, J = 0.8 Hz, 1H), 8.45 (d, J = 5.2 Hz, 1H), 7.88-7.86 (dd, J = 5.2, 1.2 Hz, 1H), 6.72 (br s, 2H).

References

[1] Patent: WO2010/68452, 2010, A1. Location in patent: Page/Page column 26
[2] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 24, p. 7357 - 7362

Isoxazolo[5,4-c]pyridin-3-amine (9CI)Supplier

SynAsst Chemical.
Tel
021-60343070
Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Email
product02@bidepharm.com
Chengdu Aslee Biopharmaceuticals, Inc
Tel
028-85305008 02885305008
Email
2306208234@qq.com
Cool Pharm, Ltd
Tel
021-60455363 18019463053
Email
sales@coolpharm.com
SuZhou ShiYa Biopharmaceuticals, Inc.
Tel
0512-0512-52358471 17715136450
Email
sales@shiyabiopharm.com